Quick Takeaways
- BlackRock, Inc. filed SCHEDULE 13G/A for PTC THERAPEUTICS, INC. Common Stock (PTCT).
- Disclosed ownership: 15%.
- Date of event: 30 Nov 2025.
BlackRock, Inc. - 30 Nov 2025 SCHEDULE 13G/A Report for PTC THERAPEUTICS, INC. Common Stock (PTCT)
- Filing Manager
- BlackRock, Inc.
- Reporting Manager
- BlackRock, Inc.
- Security
- PTC THERAPEUTICS, INC. Common Stock
- Symbol
- PTCT
- Shares outstanding
- 80,437,135 shares
- Disclosed Ownership
- 11,904,696 shares
- Ownership
- 15%
- Form type
- SCHEDULE 13G/A
- Filing time
- 04 Dec 2025, 14:24:57 UTC
- Date of event
- 30 Nov 2025
- Previous filing
- 17 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock, Inc. disclosed 15% ownership in PTC THERAPEUTICS, INC. Common Stock (PTCT) on 30 Nov 2025."
What Changed
- Previous schedule filing date: 17 Apr 2025.
- Current filing was accepted on 04 Dec 2025, 14:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 15% | 11,904,696 | 11,767,632 | 0 | Spencer Fleming | Managing Director |